References
- Aizenman E, et al. Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release. J Neurochem 2000; 75(5)1878–1888
- Allen S, et al. Use of Hoechst 33342 staining to detect apoptotic changes in bovine mononuclear phagocytes infected with Mycobacterium avium subsp. paratuberculosis. Clin Diagn Lab Immunol 2001; 8(2)460–464
- Andre N, et al. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'. Cancer Res 2000; 60(19)5349–5353
- Andre N, et al. Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett 2002; 532(1–2)256–260
- Carre M, et al. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 2002; 277(37)33664–33669
- Cha YJ, et al. Activation of caspase-8 in 3-deazaadenosine-induced apoptosis of U-937 cells occurs downstream of caspase-3 and caspase-9 without Fas receptor–ligand interaction. Exp Mol Med 2001; 33(4)284–292
- Cheng SM, et al. Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxel. J Drug Del Sci Tech 2005; 15(1)81–86
- Christensen H, et al. Lipid domains of mycobacteria studied with fluorescent molecular probes. Mol Microbiol 1999; 31(5)1561–1572
- Colston J, et al. Why fluorescent probes for endoplasmic reticulum are selective: An experimental and QSAR-modelling study. Biotech Histochem 2003; 78(6)323–332
- Druse M, et al. Signaling pathways involved with serotonin(1A) agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons. Brain Res Dev Brain Res 2005
- Eisenhauer EA, Vermorken JB. The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 1998; 55(1)5–30
- Fadok VA, Henson PM. Apoptosis: Getting rid of the bodies. Curr Biol 1998; 8(19)R693–R695
- Fan W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 1999; 57(11)1215–1221
- Fulda S, et al. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 1998; 58(19)4453–4460
- Guy R, et al. Fluorescent taxoids. Chem Biol 1996; 3(12)1021–1031
- Horobin RW. Uptake, distribution, and accumulation of dyes and fluorescent probes within living cells. A structure–activity modelling approach. Adv Col Sci Technol 2001; 4: 101–107
- Horobin RW, Stockert JC, Rashid-Doubell F. Fluorescent cationic probes for nuclei of living cells: Why are they selective? A quantitative structure–activity relations analysis. Histochem Cell Biol 2006; 126(2)165–175
- Horobin RW, Trapp S, Weissig V. Mitochondriotropics: A review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. J Control Release 2007; 121(3)125–136
- Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4)239–257
- Lim CS. Organelle-specific targeting in drug delivery and design. Adv Drug Deliv Rev 2007; 59(8)697
- Ohnishi K, et al. Glycerol as a chemical chaperone enhances radiation-induced apoptosis in anaplastic thyroid carcinoma cells. Mol Cancer 2002; 1: 4
- Patel M. Inhibition of neuronal apoptosis by a metalloporphyrin superoxide dismutase mimic. J Neurochem 1998; 71(3)1068–1074
- Rashid F, Horobin RW. Interaction of molecular probes with living cells and tissues. Part 2. A structure–activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches. Histochemistry 1990; 94(3)303–308
- Rashid F, Horobin RW. Accumulation of fluorescent non-cationic probes in mitochondria of cultured cells: Observations, a proposed mechanism, and some implications. J Microsc 1991; 163(Pt 2)233–241
- Rashid F, Horobin RW, Williams MA. Predicting the behaviour and selectivity of fluorescent probes for lysosomes and related structures by means of structure–activity models. Histochem J 1991; 23(10)450–459
- Savic R, et al. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003; 300(5619)615–618
- Seligson AL, et al. A new prodrug of paclitaxel: Synthesis of protaxel. Anticancer Drugs 2001; 12(4)305–313
- Shimizu S, et al. Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 2001; 152(2)237–250
- Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002; 235(1–2)179–192
- Stockert JC, et al. Photodynamic therapy: Selective uptake of photosensitizing drugs into tumor cells. Cur Topics Pharmacol 2004; 8: 185–217
- Wang TH, Wang HS, Soong YK. Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together. Cancer 2000; 88(11)2619–2628
- Waterhouse NJ, Ricci JE, Green DR. And all of a sudden it's over: Mitochondrial outer-membrane permeabilization in apoptosis. Biochimie 2002; 84(2–3)113–121
- Weissig V. Mitochondrial-targeted drug and DNA delivery. Crit Rev Ther Drug Carrier Syst 2003; 20(1)1–62
- Weissig V, Torchilin VP. Drug and DNA delivery to mitochondria. Adv Drug Deliv Rev 2001; 49(1–2)1–2
- Weissig V, et al. DQAsomes: A novel potential drug and gene delivery system made from Dequalinium. Pharm Res 1998; 15(2)334–337
- Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68: 251–306
- Zhang BF, et al. Staurosporine induces apoptosis in NG108-15 cells. Acta Pharmacol Sin 2003; 24(7)663–669